Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 2, 2005, Pages 170-177

  Nash, Kevin A ^a   Zhang, Yansheng ^b   Brown Elliott, Barbara A ^b   Wallace Jr , Richard J ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Clarithromycin; Erm gene; Methylase; Rapidly growing mycobacteria

Indexed keywords

BACTERIAL DNA; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; QUINUPRISTIN; RIFABUTIN; RNA METHYLTRANSFERASE; SPIRAMYCIN;

AGAR MEDIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM TRANSFORMATION; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; DNA SCREENING; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC COMPLEMENTATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM SMEGMATIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE; START CODON; STEADY STATE;

AMINO ACID SEQUENCE; DRUG RESISTANCE, BACTERIAL; HUMANS; MACROLIDES; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM FORTUITUM;

EID: 14744302956     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh523     Document Type: Article

References (35)

1. Brown-Elliott, B. A., Griffith, D. E. & Wallace, R. J., Jr (2002). Newly described or emerging human species of nontuberculous mycobacteria. Infectious Disease Clinics of North America 16, 187-220.
2. Brown-Elliott, B. A. & Wallace, R. J., Jr (2002). Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clinical Microbiology Reviews 15 716-46.
3. Bosne-David, S., Barros, V., Verde, S. C. et al. (2000). Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors. Journal of Antimicrobial Chemotherapy 46 391-5.
4. Luna-Herrera, J., Reddy, V., Daneluzzi, D. et al. (1995). Antituberculosis activity of clarithromycin. Antimicrobial Agents and Chemotherapy 39, 2692-5.
5. Garza-Ramos, G., Xiong, L., Zhong, P. et al. (2001). Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA. Journal of Bacteriology 183, 6898-907.
6. Schlunzen, F., Zarivach, R., Harms, J. et al. (2001). Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413, 814-21.
7. Zhanel, G. G., Dueck, M., Hoban, D. J. et al. (2001). Review of macrolides and ketolides: focus on respiratory tract infections. Drugs 61, 443-98.
8. Meier, A., Kirschner, P., Springer, B. et al. (1994). Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrobial Agents and Chemotherapy 38, 381-4.
9. Nash, K. A. & Inderlied, C. B. (1995). Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrobial Agents and Chemotherapy 39, 2625-30.
10. Wallace, R. J., Jr, Meier, A., Brown, B. A. et al. (1996). Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy 40, 1676-81.
11. Roberts, M. C., Sutcliffe, J., Courvalin, P. et al. (1999). Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrobial Agents and Chemotherapy 43, 2823-30.
12. Nash, K. A. (2003). Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene erm 38). Antimicrobial Agents and Chemotherapy 47, 3053-60.
13. Buriankova, K., Doucet-Populaire, F., Dorson, O. et al. (2004). Molecular basis of intrinsic macrolide resistance in the Mycobacterium tuberculosis complex. Antimicrobial Agents and Chemotherapy 48, 143-50.
14. Rosato, A. E., Lee, B. S. & Nash, K. A. (2001). Inducible macrolide resistance in Corynebacterium jeikeium. Antimicrobial Agents and Chemotherapy 45, 1982-9.
15. Telenti, A., Marchesi, F., Balz, M. et al. (1993). Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. Journal of Clinical Microbiology 31, 175-8.
16. Steingrube, V. A., Gibson, J. L., Brown, B. A. et al. (1995). PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. Journal of Clinical Microbiology 33, 149-53.
17. Wallace, R. J., Jr, Brown-Elliott, B. A., Hall, L. et al. (2002). Clinical and laboratory features of Mycobacterium mageritense. Journal of Clinical Microbiology 40, 2930-5.
18. Brown, B. A., Springer, B., Steingrube, V. A. et al. (1999). Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. International Journal of Systematic Bacteriology 49 1493-511.
19. Brown, B. A., Swenson, J. M. & Wallace, R. J., Jr (1993). Broth microdilution MIC test for rapidly growing mycobacteria. In Clinical Microbiology Procedures Handbook (Isenberg, H. D., Ed.), p. 5.11.11. American Society for Microbiology, Washington, DC, USA.
20. National Committee for Clinical Laboratory Standards. (2003). Susceptibility Testing of Mycobacteria, Nocardia, and Other Aerobic Actinomycetes - First Edition: Approved Standard M24-A. NCCLS, Villanova, PA, USA.
21. Belisle, J. T. & Sonnenberg, M. G. (1998). Isolation of genomic DNA from mycobacteria. Methods in Molecular Biology 101 31-44.
22. Stover, C. K., de la Cruz, V. F., Fuerst, T. R. et al. (1991). New use of BCG for recombinant vaccines. Nature 351, 456-60.
23. Snapper, S. B., Melton, R. E., Mustafa, S. et al. (1990). Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Molecular Microbiology 4, 1911-9.
24. Baulard, A., Jourdan, C., Mercenier, A. et al. (1992). Rapid mycobacterial plasmid analysis by electroduction between Mycobacterium spp. and Escherichia coli. Nucleic Acids Research 20, 4105.
25. Altschul, S. F., Gish, W., Miller, W. et al. (1990). Basic local alignment search tool. Journal of Molecular Biology 215, 403-10.
26. Roberts, M. C. (2003). Nomenclature Center for MLS Genes. [Online.] http://faculty.washington.edu/marilynr/ (4 June 2004, date last accessed).
27. Truffot-Pernot, C., Lounis, N., Grosset, J. H. et al. (1995). Clarithromycin is inactive against Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 39, 2827-8.
28. Mahairas, G. G., Sabo, P. J., Hickey, M. J. et al. (1996). Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. Journal of Bacteriology 178, 1274-82.
29. Kuyucu, N., Kuyucu, S., Ocal, B. et al. (1998). Comparison of oral erythromycin, local administration of streptomycin and placebo therapy for nonsuppurative Bacillus Calmette-Guerin lymphadenitis. Pediatric Infectious Disease Journal 17, 524-5.
30. Noah, P. K., Pande, D., Johnson, B. et al. (1993). Evaluation of oral erythromycin and local isoniazid instillation therapy in infants with Bacillus Calmette-Guerin lymphadenitis and abscesses. Pediatric Infectious Disease Journal 12, 136-9.
31. Goraya, J. S. & Virdi, V. S. (2002). Bacille Calmette-Guerin lymphadenitis. Postgraduate Medical Journal 78, 327-9.
32. Brown, B. A., Wallace, R. J., Jr, Onyi, G. O. et al. (1992). Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae like organisms. Antimicrobial Agents and Chemotherapy 36, 180-4.
33. Livermore, D. M. (1987). Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods. European Journal of Clinical Microbiology 6, 439-45.
34. Honore, N., Nicolas, M. H. & Cole, S. T. (1989). Regulation of enterobacterial cephalosporinase production: the role of a membrane-bound sensory transducer. Molecular Microbiology 3, 1121-30.
35. Nash, K. A. (2001). Effect of drug concentration on the emergence of macrolide resistance in Mycobacterium avium. Antimicrobial Agents and Chemotherapy 45, 1607-14.